Health Care & Life Sciences » Biotechnology | MabVax Therapeutics Holdings Inc.

MabVax Therapeutics Holdings Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
-
314.20
1,267.00
148.10
-
Cost of Goods Sold (COGS) incl. D&A
-
-
-
-
159.80
Gross Income
-
-
-
-
159.80
SG&A Expense
5,832.00
8,694.80
19,370.60
16,714.60
17,910.60
EBIT
5,832.00
8,392.90
18,124.90
16,663.10
18,070.50
Unusual Expense
591.00
475.40
19.80
-
-
Non Operating Income/Expense
8.00
0.40
0.20
-
0.50
Interest Expense
-
-
-
997.40
950.80
Pretax Income
5,230.00
7,917.90
18,105.30
17,660.50
19,020.70
Consolidated Net Income
5,230.00
7,917.90
18,105.30
17,660.50
19,020.70
Net Income
5,230.00
7,917.90
18,105.30
17,660.50
19,020.70
Net Income After Extraordinaries
5,230.00
7,917.90
18,105.30
17,660.50
19,020.70
Net Income Available to Common
5,230.00
10,577.80
36,051.50
17,660.50
32,791.40
EPS (Basic)
207.79
211.12
40.40
2.19
8.56
Basic Shares Outstanding
25.20
50.10
893.90
8,065.80
3,830.20
EPS (Diluted)
207.33
211.08
40.33
2.19
8.56
Diluted Shares Outstanding
25.20
50.10
893.90
8,065.80
3,830.20
EBITDA
5,832.00
8,380.70
18,103.50
16,566.60
17,910.60
Non-Operating Interest Income
3.00
-
-
0.00
-
Preferred Dividends
-
2,659.90
17,946.20
-
13,770.70

About MabVax Therapeutics Holdings

View Profile
Address
11535 Sorrento Valley Road
San Diego California 92121
United States
Employees -
Website http://www.mabvax.com
Updated 09/14/2018
MabVax Therapeutics Holdings, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing innovative vaccine and monoclonal antibody-based therapeutics for the diagnosis and treatment of cancer. The company was founded on July 8, 2014 and is headquartered in San Diego, CA. .

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.